Abstract
The FDA Food Quality Protection Act of 1996 and amendments to the EPA Safe Drinking Water Act require the EPA Administrator, in consultation with the Secretary of Health and Human Services, to develop a screening program for endocrine disrupting effects. This Comment explores the science of endocrine disruptors and examines whether the current science supports a successful products liability claim. The various methods for proving liability, causation and harm are presented and analyzed against the current science of endocrine disruption. This Comment suggests possible ways the court might allow plaintiffs to present evidence of causation in bringing suit against companies that add endocrine disruptors to their products. Despite this a plaintiff bringing such an action still has formidable hurdles to overcome.
Recommended Citation
Karen Fassuliotis, The Science of Endocrine Disruption - Will It Change the Scope of Products Liability Claims?, 17 Pace Envtl. L. Rev. 351 (2000)DOI: https://doi.org/10.58948/0738-6206.1286
Available at: https://digitalcommons.pace.edu/pelr/vol17/iss2/4